Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol
ConditionSolid Tumor
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMemorial Sloan Kettering Cancer Center
About this trial
The purpose of this study is to develop a secure method of collecting physiologic information from patients with cancer. The researchers will use this information to learn more about how physiologic data may relate to cancer diagnosis and response to treatment, and to identify factors that may lead to higher or lower risk of cancer.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Diagnosis of new onset early-stage (I-III), low-grade (I-II), or locally advanced solid tumor
Historical diagnosis of primary invasive solid tumor
Diagnosis of metastatic (stage IV) or high-grade (III-IV) disease
Enrolled onto an investigational trial in the EDD Service
Disqualifiers
Unable or unwilling to successfully export and /or share physiological data
Unable or unwilling to appropriately use digital platforms or devices
Require a wheelchair for ambulation (Cohort 10)
Are undergoing stabilization surgery for a primary bone tumor (rather than metastatic disease) (Cohort 10)
Trial population
Potential participants will be identified by a member of the patient's care team, a protocol investigator, or research staff at Memorial Sloan Kettering Cancer Center (MSK).
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
establish a mechanism within the institution to prospectively collect / extract digital remote physiological data among patients with cancer
to create a repository and infrastructure to address novel questions of clinical importance.
Time frame
1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov